These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 11861912)

  • 41. Studying TDP1 Function in DNA Repair.
    Chiang SC; Liversidge K; El-Khamisy SF
    Methods Mol Biol; 2018; 1703():173-181. PubMed ID: 29177742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1.
    Antony S; Marchand C; Stephen AG; Thibaut L; Agama KK; Fisher RJ; Pommier Y
    Nucleic Acids Res; 2007; 35(13):4474-84. PubMed ID: 17576665
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A human 5'-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage.
    Cortes Ledesma F; El Khamisy SF; Zuma MC; Osborn K; Caldecott KW
    Nature; 2009 Oct; 461(7264):674-8. PubMed ID: 19794497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Substrate specificity of tyrosyl-DNA phosphodiesterase I (Tdp1).
    Raymond AC; Staker BL; Burgin AB
    J Biol Chem; 2005 Jun; 280(23):22029-35. PubMed ID: 15811850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis of 11-aminoalkoxy substituted benzophenanthridine derivatives as tyrosyl-DNA phosphodiesterase 1 inhibitors and their anticancer activity.
    Yang H; Wang FT; Wu M; Wang W; Agama K; Pommier Y; An LK
    Bioorg Chem; 2022 Jun; 123():105789. PubMed ID: 35429714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP1.
    Dyrkheeva NS; Filimonov AS; Luzina OA; Orlova KA; Chernyshova IA; Kornienko TE; Malakhova AA; Medvedev SP; Zakharenko AL; Ilina ES; Anarbaev RO; Naumenko KN; Klabenkova KV; Burakova EA; Stetsenko DA; Zakian SM; Salakhutdinov NF; Lavrik OI
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy.
    Dexheimer TS; Antony S; Marchand C; Pommier Y
    Anticancer Agents Med Chem; 2008 May; 8(4):381-9. PubMed ID: 18473723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TDP1 knockout Leishmania donovani accumulate topoisomerase 1-linked DNA damage and are hypersensitive to clinically used antileishmanial drugs.
    Chowdhury SR; Das SK; Banerjee B; Paul Chowdhuri S; Majumder HK; Das BB
    FASEB J; 2022 Apr; 36(4):e22265. PubMed ID: 35319800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Probing the evolutionary conserved residues Y204, F259, S400 and W590 that shape the catalytic groove of human TDP1 for 3'- and 5'-phosphodiester-DNA bond cleavage.
    Kiselev E; Dexheimer TS; Marchand C; Huang SN; Pommier Y
    DNA Repair (Amst); 2018; 66-67():64-71. PubMed ID: 29747024
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Tyrosyl-DNA Phosphodiesterase 1 Is a New Player in Repair of Apurinic/Apyrimidinic Sites].
    Rechkunova NI; Lebedeva NA; Lavrik OI
    Bioorg Khim; 2015; 41(5):531-8. PubMed ID: 26762090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide.
    Davies DR; Interthal H; Champoux JJ; Hol WG
    Chem Biol; 2003 Feb; 10(2):139-47. PubMed ID: 12618186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors.
    Huang SN; Pommier Y; Marchand C
    Expert Opin Ther Pat; 2011 Sep; 21(9):1285-92. PubMed ID: 21843105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tyrosyl-DNA Phosphodiesterase I N-Terminal Domain Modifications and Interactions Regulate Cellular Function.
    Brettrager EJ; Segura IA; van Waardenburg RCAM
    Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31698852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily.
    Interthal H; Pouliot JJ; Champoux JJ
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12009-14. PubMed ID: 11572945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The crystal structure of human tyrosyl-DNA phosphodiesterase, Tdp1.
    Davies DR; Interthal H; Champoux JJ; Hol WG
    Structure; 2002 Feb; 10(2):237-48. PubMed ID: 11839309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tyrosyl-DNA phosphodiesterase 1 targeting for modulation of camptothecin-based treatment.
    Beretta GL; Cossa G; Gatti L; Zunino F; Perego P
    Curr Med Chem; 2010; 17(15):1500-8. PubMed ID: 20166932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SCAN1 mutant Tdp1 accumulates the enzyme--DNA intermediate and causes camptothecin hypersensitivity.
    Interthal H; Chen HJ; Kehl-Fie TE; Zotzmann J; Leppard JB; Champoux JJ
    EMBO J; 2005 Jun; 24(12):2224-33. PubMed ID: 15920477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Yeast gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes.
    Pouliot JJ; Yao KC; Robertson CA; Nash HA
    Science; 1999 Oct; 286(5439):552-5. PubMed ID: 10521354
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TDP1 deficiency sensitizes human cells to base damage via distinct topoisomerase I and PARP mechanisms with potential applications for cancer therapy.
    Alagoz M; Wells OS; El-Khamisy SF
    Nucleic Acids Res; 2014 Mar; 42(5):3089-103. PubMed ID: 24335147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TDP1 is required for efficient non-homologous end joining in human cells.
    Li J; Summerlin M; Nitiss KC; Nitiss JL; Hanakahi LA
    DNA Repair (Amst); 2017 Dec; 60():40-49. PubMed ID: 29078113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.